Thalidomide does not improve survival in small cell lung cancer
Links shared publicly online about this topic.
- 1,893total visits
Thalidomide does not improve survival in small cell lung cancer
View full resource at physorg.com
Tags: Leprosy Medication, Cancer, Chemotherapy, Lung Cancer, Small Cell Lung Cancer, Lung, Thalomid, Thalidomide
Most Recently Shared on July 16, 2009 at 8:44 pm By:
Thalidomide does not improve survival in small cell lung cancer http://bit.ly/mTnzL
MedWire News - Oncology - NSCLC survival not improved by addition of bevacizumab to erlotinib
medwire-news.md — “MedWire News Addition of bevacizumab to erlotinib does not improve overall survival in patients with recurrent or refractory non-small-cell lung cancer after first-line treatment failure, results of an international, phase III clinical trial show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on June 1, 2011 at 9:24 am By:
NSCLC survival not improved by addition of bevacizumab to erlotinib http://bit.ly/jxDVeA #oncology
AE-941, a Standardized Shark Cartilage, Does Not Improve Lung Cancer Survival -- , 10.1093/jnci/djq221 -- JNCI Journal of the National Cancer Institute
jnci.oxfordjournals.org — “AE-941, a Standardized Shark Cartilage, Does Not Improve Lung Cancer Survival -- , 10.1093/jnci/djq221 -- JNCI Journal of the National Cancer Institute” View full resource at jnci.oxfordjournals.org
Most Recently Shared on May 27, 2010 at 4:47 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Anti-angiogenic shark cartilage derivative shown not to improve stage III non-small cell lung cancer survival. http://tinyurl.com/36m9ya5
AE-941, a standardized shark cartilage, does not improve lung cancer survival
physorg.com — “The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May 26 in the Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on May 26, 2010 at 11:45 pm By:
Mona Jauhar Health Professional
AE-941, a standardized shark cartilage, does not improve lung cancer survival: The anti-cancer drug AE-941, a shar... http://bit.ly/cHSkJw
AE-941, a standardized shark cartilage, does not improve lung cancer survival
physorg.com — “The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May 26 in the Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on May 26, 2010 at 11:30 pm By:
PhysOrg Health News Health News
AE-941, a standardized shark cartilage, does not improve lung cancer survival http://tw.physorg.com/194118381
Hopes Dashed for Thalidomide as Lung Cancer Treatment - Drugs.com MedNews
drugs.com — “Using the drug thalidomide in combination with chemotherapy won t improve survival for patients with small cell lung cancer but does increase their risk of bloo” View full resource at drugs.com
Most Recently Shared on July 17, 2009 at 5:47 am By:
Hopes Dashed for Thalidomide as Lung Cancer Treatment - http://bit.ly/3bHww
Advertisement
